AVE STOCK CLIMBS 13% IN JANUARY ON COMPANY PRODUCT APPROVALS, STRONG WORLDWIDE CORONARY STENT MARKET OUTLOOK; O-T-C INDEX COMPOSITE UP 3.2%
This article was originally published in The Gray Sheet
Executive Summary
Arterial Vascular Engineering stock's January debut on "The Gray Sheet" Index coincided with a solid 8-1/2 point (13.1%) run-up during the month to 73-1/2. Investor enthusiasm for the issue, roused by the Dec. 23 approval of the company's Micro Stent II and GFX coronary stent systems, was heightened further by Wall Street predictions of "explosive" stent market growth in 1998.